New study aims to predict relapse in common blood vessel disease
NCT ID NCT07246577
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for 340 people with suspected giant cell arteritis (GCA), a condition that causes inflammation in blood vessels and is usually treated with long-term steroids. The goal is to find better ways to predict who will have relapses and to monitor the disease using ultrasound and blood tests. By improving these tools, doctors hope to personalize treatment and reduce side effects from steroids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sahlgrenska Universitetssjukhuset
RECRUITINGGothenburg, 41345, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can frequent CRP checks prevent relapses in giant cell arteritis?
- Ultrasound clue vanishes days after steroids start in artery disease
- New Total-Body PET scanner could revolutionize vasculitis diagnosis
- New drug combo aims to tame blood vessel inflammation
- Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
- New ultrasound method could predict relapses in rare artery disease